HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yair Lotan Selected Research

Protein Isoforms (Isoforms)

1/2022Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study.
1/2019Clinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yair Lotan Research Topics

Disease

182Neoplasms (Cancer)
02/2024 - 01/2002
170Urinary Bladder Neoplasms (Bladder Cancer)
03/2024 - 01/2002
149Carcinoma (Carcinomatosis)
07/2023 - 02/2004
51Prostatic Neoplasms (Prostate Cancer)
01/2023 - 06/2004
30Non-Muscle Invasive Bladder Neoplasms
02/2024 - 09/2009
28Neoplasm Metastasis (Metastasis)
01/2022 - 06/2004
26Lymphatic Metastasis
05/2023 - 02/2004
25Renal Cell Carcinoma (Grawitz Tumor)
02/2023 - 10/2006
20Transitional Cell Carcinoma
04/2014 - 01/2002
19Margins of Excision
01/2023 - 06/2004
17Carcinoma in Situ
01/2017 - 09/2006
15Disease Progression
02/2024 - 02/2004
10Hematuria
01/2023 - 07/2010
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 03/2011
6Infections
10/2023 - 11/2003
6Adenocarcinoma
11/2018 - 05/2007
6Shock
07/2011 - 04/2002
5Kidney Neoplasms (Kidney Cancer)
12/2020 - 08/2012
5Extranodal Extension
10/2014 - 06/2004
5Carcinogenesis
06/2014 - 11/2007
5Obesity
01/2014 - 05/2008
4Pain (Aches)
12/2019 - 09/2009
4Necrosis
01/2017 - 11/2015
3Aneuploidy (Aneuploid)
01/2023 - 10/2008
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
06/2021 - 01/2020
3Hydronephrosis
01/2021 - 01/2011
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021 - 11/2005
3Testicular Neoplasms (Testicular Cancer)
01/2018 - 11/2002
3Diabetes Mellitus
08/2014 - 12/2013
3Urolithiasis
07/2011 - 06/2008
3Hemorrhage
08/2005 - 06/2002
2COVID-19
12/2023 - 12/2020
2Pathologic Constriction (Stenosis)
01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

69Biomarkers (Surrogate Marker)IBA
02/2023 - 11/2005
21Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 06/2004
16Proteins (Proteins, Gene)FDA Link
02/2023 - 05/2007
15Cisplatin (Platino)FDA LinkGeneric
03/2024 - 06/2008
14Tumor Biomarkers (Tumor Markers)IBA
02/2023 - 01/2002
14nuclear matrix protein 22IBA
04/2016 - 05/2005
10SurvivinIBA
11/2015 - 02/2004
9Phenobarbital (Luminal)FDA Link
01/2022 - 01/2019
8DNA (Deoxyribonucleic Acid)IBA
02/2023 - 07/2011
7Messenger RNA (mRNA)IBA
02/2024 - 08/2014
75-aminolevulinic acid hexyl esterFDA Link
01/2022 - 01/2018
6LipidsIBA
06/2022 - 12/2015
6CyclinsIBA
11/2016 - 12/2006
5EnzymesIBA
11/2019 - 03/2011
4GemcitabineFDA Link
05/2023 - 06/2008
4Glucose (Dextrose)FDA LinkGeneric
02/2023 - 09/2017
4RNA (Ribonucleic Acid)IBA
02/2023 - 08/2017
4Indicators and Reagents (Reagents)IBA
01/2023 - 08/2010
4Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2023 - 01/2018
4AndrogensIBA
01/2020 - 08/2013
4Finasteride (Propecia)FDA LinkGeneric
05/2016 - 03/2005
4Cyclin EIBA
01/2015 - 03/2011
3Dihydrotachysterol (AT 10)IBA
12/2023 - 11/2013
3Tricarboxylic AcidsIBA
02/2023 - 09/2017
3NucleotidesIBA
01/2023 - 09/2017
3PlatinumIBA
01/2022 - 10/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 04/2015
3Immune Checkpoint InhibitorsIBA
10/2021 - 01/2017
3MicroRNAs (MicroRNA)IBA
04/2021 - 12/2015
3hydrogen sulfite (bisulfite)IBA
11/2019 - 07/2011
3Caveolin 1IBA
01/2019 - 05/2007
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2016 - 06/2008
3Methotrexate (Mexate)FDA LinkGeneric
04/2016 - 06/2008
3Vinblastine (Vinblastine Sulfate)FDA Link
04/2016 - 06/2008
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2015 - 07/2013
3AntigensIBA
04/2015 - 09/2013
3TOR Serine-Threonine KinasesIBA
01/2015 - 03/2013
3Metformin (Glucophage)FDA LinkGeneric
08/2014 - 12/2013
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2011 - 03/2007
3Hemostatics (Antihemorrhagics)IBA
08/2005 - 06/2002
2Interleukin-6 (Interleukin 6)IBA
02/2024 - 01/2022
2Carboplatin (JM8)FDA LinkGeneric
05/2023 - 11/2022
2Interleukin-8 (Interleukin 8)IBA
01/2023 - 04/2021
2mesoglycanIBA
01/2023 - 07/2015
2Formaldehyde (Formol)FDA Link
01/2023 - 03/2018

Therapy/Procedure

122Cystectomy
03/2024 - 09/2005
77Therapeutics
02/2024 - 06/2004
60Nephroureterectomy
07/2023 - 07/2008
40Lymph Node Excision (Lymph Node Dissection)
03/2024 - 11/2002
38Drug Therapy (Chemotherapy)
03/2024 - 12/2006
33Neoadjuvant Therapy
03/2024 - 10/2006
30Prostatectomy (Retropubic Prostatectomy)
01/2021 - 06/2004
28Adjuvant Chemotherapy
01/2021 - 10/2006
20Radiotherapy
11/2021 - 02/2006
17Nephrectomy
01/2021 - 04/2004
12Immunotherapy
01/2022 - 10/2012
8Transurethral Resection of Bladder
12/2023 - 11/2016
7Lithotripsy (Extracorporeal Shockwave Lithotripsy)
12/2012 - 04/2002
5Radiofrequency Ablation
01/2016 - 12/2003
4Length of Stay
01/2020 - 11/2002
3Induction Chemotherapy
03/2024 - 01/2016
3Aftercare (After-Treatment)
01/2021 - 05/2006
3Adjuvant Radiotherapy
08/2017 - 10/2006
3Chemoprevention
02/2011 - 08/2006
3Operative Surgical Procedures
09/2009 - 11/2004
3Lasers (Laser)
08/2007 - 06/2002
2Stents
01/2023 - 01/2021